Min Hu
Senior Vice President, Discovery Innovent Biologics
Min Hu, Ph.D., is Senior Vice President of Discovery at Innovent Biologics, bringing over two decades of scientific and leadership experience in oncology and drug research. She previously held key R&D leadership roles at Shanghai Hengrui Pharmaceuticals, advancing from Director to Vice President, and earlier served as a Principal Scientist at AstraZeneca and Investigator at Novartis. Dr. Hu holds a Ph.D. in Basic Medical Sciences from Purdue University and has contributed to multiple international patent applications in gene methylation and oncology biomarkers, alongside an extensive publication record spanning cancer biology and therapeutic development.
Seminars
Tuesday 13th October 2026
Panel Discussion: Contextualizing the Current Status of Novel ADC Design & Development to Ensure Future ADC Success & Differentiated Patient Impact
8:00 am
- Evaluating the landscape of ADC therapies one year on: Is the field pursuing the right amount of innovation to secure the next wave of ADCs beyond Topo1?
- Delving into payload mechanisms and non-traditional ADC design: What avenues of innovation are showing promise and what needs to be demonstrated?
- Assessing hurdles and opportunities to achieve differentiated ADC clinical profiles and patient impact in crowded oncology indications
- Peering into the crystal ball: Debating the future direction of the ADC field and pioneering future possibilities
